AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
Lenalidomide in Ghana
6 products registered with FDA Ghana — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ADCCLENA 10MG TABLETS | UNKNOWN-90f6de7a | — | active | 1 May 2030 |
| ADCCLENA 15MG TABLETS | UNKNOWN-df4fb1f8 | — | active | 1 May 2030 |
| ADCCLENA 5MG TABLETS | UNKNOWN-6893d96b | — | active | 1 May 2030 |
| ADCCLENA 5MG TABLETS | UNKNOWN-119a54fb | — | active | 1 May 2030 |
| ADCCLENA 10MG TABLETS | UNKNOWN-45f3c125 | — | active | 1 May 2030 |
| ADCCLENA 15MG TABLETS | UNKNOWN-1ef8e3ab | — | active | 1 May 2030 |
Lenalidomide — FDA Ghana Registration Details
FDA Ghana (Ghana) has 6 registered products containing Lenalidomide, of which 6 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track Lenalidomide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.